Almonty Q2 Results Show Continued Losses as Sangdong Ramp Starts, First Revenue Still Elusive

What happened

Almonty Industries reported second-quarter 2026 financial results after the market close on August 11, confirming that the Sangdong processing plant began feeding stockpiled ore in June but generated no revenue for the period. The quarter likely saw higher earnings from Panasqueira due to surging tungsten prices, but operating losses persisted because of ramp-up costs and interest on the US$800 million convertible notes issued in June. The stock still trades near $14, pricing in successful commercial production even though no official first shipment or recovery data has been disclosed. While management may paint an optimistic picture of commissioning progress, the absence of hard output numbers means the thesis remains one of execution risk rather than proven cash generation. The updated GTP offtake and defense tailwinds are supportive, but the near-term catalyst is missing from these numbers.

Implication

The Q2 2026 results are unlikely to change the investment thesis: Almonty remains a tungsten ramp story with strategic offtake but no disclosed commercial production. The reported quarter will show continued reliance on Panasqueira and a strong cash position from the convert, but profits are still absent. Without confirmed first delivery or throughput data, the stock’s current valuation discounts a success that isn’t yet in the numbers. Investors should monitor disclosures for Sangdong KPIs and GTP delivery timing; until then, the wait-and-see stance is warranted. The balance of risk and reward suggests a continued rating of WAIT, with attractive entry near $11 and a trim above $17.

Thesis delta

The Q2 results do not alter the core thesis: Sangdong ramp remains unverified, and first shipment is the critical missing catalyst. The financials likely reflect a pre-revenue profile, and the capital structure has been bolstered, but execution risk dominates.